Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Recruiting Phase 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0115749 (Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00801489Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeTreatment